Edward Reno is a partner at bipartisan consulting firm Forbes Tate Partners where he advises organizations on congressional and administration strategies. He has extensive experience in the public and private sectors developing policy and strategies related to federal and international regulations.
Reno has spent his career working in federal and state government and in corporations where he worked to develop policy and strategies related to global and U.S. federal and state law/regulations. At Forbes Tate Partners, he co-leads the healthcare and mergers & acquisitions practices where he advises organizations on such issues as congressional and administration strategies, approval and market access strategies, managing congressional oversight issues, and managing merger and acquisition reviews by legislative and regulatory authorities in Washington, D.C.
Reno serves on the Board of Advisors at Goldman Edwards, LLC, a leading information technologies service provider, and he is an Advisor to IACTA Pharmaceuticals, a leading drug development company focusing on the ophthalmic marketplace.
Earlier in his career, Reno established Strathspey Crown, LLC’s government affairs organization as the start-up developed disruptive technologies in the biotech space – this work has notably led to the launch and IPO of Evolus, which Mr. Reno still advises, as well as other innovative healthcare companies. Prior to Strathspey Crown, Reno was the Chief Government Affairs Officer for Allergan, Inc., a specialty pharmaceutical, biotechnology and medical device company. In this role, he was responsible for creating and executing the company’s advocacy strategy on policy issues related to drug approvals, marketplace impacting laws and regulations, tax, trade, antitrust, and general business issues.
Reno has also worked in the U.S. Senate and the Governor’s Office of the State of California. He earned a B.A. in political science from the University of Southern California and an MBA from Northwestern University’s Kellogg School of Management.